Curis
CRIS
#10437
Rank
A$20.97 M
Marketcap
A$0.54
Share price
-8.61%
Change (1 day)
-85.89%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.20. In 2024 the company made an earnings per share (EPS) of A-$9.95 an increase over its 2023 EPS that were of A-$12.78.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-41.86%
2024A-$9.95-22.15%
2023A-$12.78-26.17%
2022A-$17.3222.3%
2021A-$14.16-25.37%
2020A-$18.97-30.93%
2019A-$27.47-2.02%
2018A-$28.03
2016A-$63.71-10%
2015A-$70.79138.1%
2014A-$29.7340%
2013A-$21.24-25%
2012A-$28.3266.67%
2011A-$16.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.85-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.04-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.43-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.51 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$15.91 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.00-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA